Refined TNM-staging for pancreatic adenocarcinoma – Real progress or much ado about nothing?

In order to provide optimal cancer care and prognostication, it is necessary to stage the disease. The 8th edition of the TNM-staging for exocrine pancreatic ductal adenocarcinoma (PDAC) system has refined size-based T-stages and number-based N-categories. However, several impediments to the value o...

Full description

Saved in:
Bibliographic Details
Published in:European journal of surgical oncology 2020-08, Vol.46 (8), p.1554-1557
Main Authors: Roalsø, Marcus, Aunan, Jan Rune, Søreide, Kjetil
Format: Article
Language:English
Subjects:
Biomarkers
Carcinoma, Pancreatic Ductal - pathology
Carcinoma, Pancreatic Ductal - surgery
Humans
Molecular subtypes
Neoplasm Staging
Pancreatic cancer
Pancreatic Neoplasms - pathology
Pancreatic Neoplasms - surgery
Staging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In order to provide optimal cancer care and prognostication, it is necessary to stage the disease. The 8th edition of the TNM-staging for exocrine pancreatic ductal adenocarcinoma (PDAC) system has refined size-based T-stages and number-based N-categories. However, several impediments to the value of this may exist. For one, even at small size (e.g.
ISSN:0748-7983
1532-2157
DOI:10.1016/j.ejso.2020.02.014